This page provides detailed guidance for companies intending to apply for a paediatric investigation plan (PIP), waiver, deferral or product-specific waiver, as well as for companies that already have an agreed PIP.

HumanRegulatory and procedural guidancePaediatricsResearch and development

The European Medicines Agency's scientific guidelines on specific types of products help medicine developers prepare marketing authorisation applications for human medicines.

HumanRegulatory and procedural guidanceQuality of medicinesResearch and developmentScientific guidelines
VeterinaryRegulatory and procedural guidanceQuality of medicinesResearch and developmentScientific guidelines

This page lists the templates and forms required by companies wishing to apply for a paediatric investigation plan (PIP), deferral or waiver. Deadlines for submitting applications to the Paediatric Committee (PDCO) are also available below.

HumanRegulatory and procedural guidancePaediatricsResearch and development